Market Tracker

01/18 4:50am ET

Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)

1.95
Delayed Data
As of Jan 17
 -0.11 / -5.34%
Today’s Change
1.20
Today|||52-Week Range
8.22
+25.81%
Year-to-Date

Today’s Trading

Previous close2.06
Today’s open2.06
Day’s range1.88 - 2.06
Volume1,362,556
Average volume (3 months)1,735,431
Market cap$152.8M
Dividend yield--
Data as of 01/17/2017

Growth & Valuation

Earnings growth (last year)+16.25%
Earnings growth (this year)+60.90%
Earnings growth (next 5 years)--
Revenue growth (last year)-58.55%
P/E ratioNM
Price/Sales2,834.05
Price/Book1.50

Competitors

 Today’s
change
Today’s
% change
AVXLAnavex Life Sciences...-0.08-1.93%
CASCCascadian Therapeuti...-0.42-9.07%
CDXSCodexis Inc-0.15-3.06%
BCLIBrainstorm Cell Ther...-0.06-2.17%
Data as of 01/17/2017

Financials

Next reporting dateFebruary 7, 2017
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$158.3K
Annual profit (last year)-$81.7M
Net profit margin-51,614.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Christopher Richard Anzalone
Chief Operating Officer
Bruce D. Given
Corporate headquarters
Pasadena, California

Forecasts